EUVIMED · CrossrefZeitschrift
Cancer Chemotherapy and Pharmacology
ISSN 1432-0843 · Springer Science and Business Media LLC
Neueste Artikel
Single-dose pharmacokinetics and bioavailability of a novel anticancer naphthoquinone–triazole hybrid in rats
Integrating RNA technologies with CAR-T cell therapy: strategies to overcome current limitations and expand clinical applications
A phase 1 study of 4’-thio-2’-deoxycytidine in patients with solid tumors
CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas
Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4
Evaluation of anticancer activity of beta glucan in non-alcoholic steatohepatitis associated hepatocellular carcinoma in rats
Window of opportunity study measuring defactinib and avutometinib delivery in glioblastomas
Synergistic interactions and optimal sequencing of chemotherapy and immunotherapy in cancer treatment
Recent advances in bispecific antibody-drug conjugates for breast cancer therapy
Curcumin in colorectal cancer: preventive strategies and therapeutic mechanisms
A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)
HER-2 SMASH
Pharmacokinetic analysis of crushed venetoclax tablets combined with azacitizine for recurrent pediatric acute myeloid leukemia (AML)
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment
New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
Neurofilament light chain as a marker for neuronal damage: integrating in vitro studies and clinical findings in patients with oxaliplatin-induced neuropathy
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study
Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancer
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with “quadruple wild-type” (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Anlotinib in cancer therapy: mechanisms of action, clinical applications, and future perspectives
Non-oncologic to oncologic drug: A systematic review of drug repurposing in cancer
Sacituzumab Govitecan initial dose reduction in polish patients with metastatic triple-negative breast cancer: impact on efficacy and safety
Dosing chemotherapy in children with obesity: literature review and evaluation of local practices
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors
Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells
Jahrgänge
2026 · 702025 · 1272024 · 1352023 · 982022 · 1332021 · 1812020 · 2012019 · 2612018 · 2362017 · 2682016 · 2822015 · 2872014 · 2882013 · 3312012 · 2872011 · 3602010 · 2512009 · 2982008 · 2382007 · 1972006 · 2702005 · 1772004 · 1802003 · 1602002 · 1492001 · 1882000 · 1381999 · 1851998 · 1331997 · 1871996 · 2031995 · 3371994 · 4271993 · 1781992 · 2591991 · 1631990 · 2371989 · 2791988 · 1441987 · 177
EUVIMED